Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used as a stimulant laxative for the evacuation of the bowel.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., colonoscopy, barium enema).
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** 1 bottle (typically 4.5 oz or 133 mL) administered rectally as a single dose. May be repeated in 24 hours if necessary, as per institutional protocol.
* **Constipation Relief:** 1 bottle (typically 4.5 oz or 133 mL) administered rectally as a single dose.
## Pediatric Dosing
* **Ages 2-11 years:** 1/2 bottle (typically 2.25 oz or 66.5 mL) administered rectally as a single dose.
* **Under 2 years:** Use is generally not recommended due to increased risk of electrolyte imbalance and dehydration. Consult product labeling or specialist.
## Dose Adjustments
* No specific dose adjustments are typically required for hepatic or renal impairment, but caution is warranted due to potential for electrolyte disturbances.
## Contraindications
* Congestive heart failure
* Severe renal impairment
* Congenital or acquired megacolon
* Ileus
* Bowel obstruction
* Known or suspected gastrointestinal perforation
* Children under 2 years of age (relative contraindication due to safety concerns)
* Patients with impaired ability to retain the enema
* Patients with hyperphosphatemia or hypocalcemia
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:**
* **Electrolyte imbalances:** Hyperphosphatemia, hypocalcemia, hyponatremia, hypernatremia, acidosis. Symptoms can include muscle cramps, tetany, seizures, cardiac arrhythmias, dehydration, kidney injury.
* **Gastrointestinal:** Rarely, ulcerations, perforation.
## Key Drug Interactions
* **Diuretics (Thiazide and Loop):** Increased risk of electrolyte disturbances.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **Calcium channel blockers:** Increased risk of hyperkalemia.
* **Medications affecting potassium levels:** Concurrent use with other agents that can alter potassium balance should be approached with caution.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, decreased urine output, muscle cramps, confusion, dizziness).
* Electrolyte panels (phosphate, calcium, sodium, potassium) may be considered in at-risk patients (e.g., elderly, those with renal impairment, repeated use).
## Clinical Pearls
* Ensure adequate hydration before and after administration, especially in pediatric patients and the elderly.
* Instruct patients to retain the enema for the recommended time (typically 2-5 minutes) for optimal effectiveness.
* Avoid prolonged or excessive use to prevent electrolyte disturbances and laxative dependence.
* Consider alternative bowel preparation agents for patients with contraindications or increased risk factors for electrolyte abnormalities.
***
*Please verify current prescribing information with the manufacturer's labeling.*
